These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25866149)

  • 21. Adjustment for baseline characteristics in randomized trials using logistic regression: sample-based model versus true model.
    Perneger T; Combescure C; Poncet A
    Trials; 2023 Feb; 24(1):107. PubMed ID: 36782238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Categorisation of continuous covariates for stratified randomisation: How should we adjust?
    Sullivan TR; Morris TP; Kahan BC; Cuthbert AR; Yelland LN
    Stat Med; 2024 May; 43(11):2083-2095. PubMed ID: 38487976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity of tests under covariate-adaptive biased coin randomization and generalized linear models.
    Shao J; Yu X
    Biometrics; 2013 Dec; 69(4):960-9. PubMed ID: 23848580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjusting power for a baseline covariate in linear models.
    Glueck DH; Muller KE
    Stat Med; 2003 Aug; 22(16):2535-51. PubMed ID: 12898543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust extraction of covariate information to improve estimation efficiency in randomized trials.
    Moore KL; Neugebauer R; Valappil T; Laan MJ
    Stat Med; 2011 Aug; 30(19):2389-408. PubMed ID: 21751231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates.
    Li Y; Ma W; Qin Y; Hu F
    Stat Methods Med Res; 2021 Sep; 30(9):2148-2164. PubMed ID: 33899607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.
    Yang S; Starks MA; Hernandez AF; Turner EL; Califf RM; O'Connor CM; Mentz RJ; Roy Choudhury K
    Contemp Clin Trials; 2020 Jan; 88():105775. PubMed ID: 31228563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes.
    Garofolo KM; Yeatts SD; Ramakrishnan V; Jauch EC; Johnston KC; Durkalski VL
    Trials; 2013 Apr; 14():98. PubMed ID: 24499406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.
    Ciolino J; Zhao W; Martin R; Palesch Y
    Contemp Clin Trials; 2011 Mar; 32(2):250-9. PubMed ID: 21078415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covariate adjustment in randomized clinical trials with missing covariate and outcome data.
    Chang CR; Song Y; Li F; Wang R
    Stat Med; 2023 Sep; 42(22):3919-3935. PubMed ID: 37394874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
    Kristunas C; Grayling M; Gray LJ; Hemming K
    BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for covariate adjustment in cost-effectiveness analysis that use cluster randomised trials.
    Gomes M; Grieve R; Nixon R; Ng ES; Carpenter J; Thompson SG
    Health Econ; 2012 Sep; 21(9):1101-18. PubMed ID: 22461149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing longitudinal binary data in clinical studies.
    Li Y; Feng D; Sui Y; Li H; Song Y; Zhan T; Cicconetti G; Jin M; Wang H; Chan I; Wang X
    Contemp Clin Trials; 2022 Apr; 115():106717. PubMed ID: 35240309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties and pitfalls of weighting as an alternative to multilevel multiple imputation in cluster randomized trials with missing binary outcomes under covariate-dependent missingness.
    Turner EL; Yao L; Li F; Prague M
    Stat Methods Med Res; 2020 May; 29(5):1338-1353. PubMed ID: 31293199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of an incomplete binary outcome dichotomized from an underlying continuous variable in clinical trials.
    Ma C; Shen X; Qu Y; Du Y
    Pharm Stat; 2022 Sep; 21(5):907-918. PubMed ID: 35277928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.